Phio Pharmaceuticals Corp. (PHIO)
NASDAQ: PHIO · Real-Time Price · USD
1.210
+0.050 (4.31%)
At close: Mar 9, 2026, 4:00 PM EDT
1.200
-0.010 (-0.83%)
After-hours: Mar 9, 2026, 5:35 PM EDT
Phio Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | -8.7 | -7.15 | -10.83 | -11.48 | -13.29 | |
| Depreciation & Amortization | 0 | 0.04 | 0.18 | 0.19 | 0.19 | |
| Loss (Gain) From Sale of Assets | - | -0.01 | - | - | - | |
| Asset Writedown & Restructuring Costs | - | - | 0.13 | - | - | |
| Stock-Based Compensation | 0.48 | 0.15 | 0.3 | 0.41 | 0.48 | |
| Other Operating Activities | - | - | - | - | -0.23 | |
| Change in Accounts Payable | 0.18 | -0.4 | -0.12 | 0.5 | -0.45 | |
| Change in Other Net Operating Assets | 0.05 | 0.27 | -0.41 | -1.75 | 1.44 | |
| Operating Cash Flow | -7.98 | -7.11 | -10.75 | -12.13 | -11.86 | |
| Capital Expenditures | -0.01 | -0 | -0.01 | -0.12 | -0.05 | |
| Sale of Property, Plant & Equipment | - | 0.01 | - | - | - | |
| Investing Cash Flow | -0.01 | 0.01 | -0.01 | -0.12 | -0.05 | |
| Issuance of Common Stock | 23.67 | 4 | 7.45 | - | 21.72 | |
| Repurchase of Common Stock | -0.03 | -0.01 | -0.04 | -0.03 | -0 | |
| Financing Cash Flow | 23.64 | 4 | 7.41 | -0.03 | 21.72 | |
| Net Cash Flow | 15.65 | -3.11 | -3.34 | -12.28 | 9.81 | |
| Free Cash Flow | -7.99 | -7.11 | -10.75 | -12.25 | -11.91 | |
| Free Cash Flow Per Share | -1.33 | -9.03 | -46.45 | -97.00 | -100.24 | |
| Cash Interest Paid | - | 0.01 | 0.01 | - | - | |
| Levered Free Cash Flow | -5.54 | -4.54 | -6.58 | -7.81 | -6.71 | |
| Unlevered Free Cash Flow | -5.54 | -4.54 | -6.58 | -7.81 | -6.71 | |
| Change in Working Capital | 0.24 | -0.14 | -0.54 | -1.26 | 0.99 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.